NCT05517811Recruiting
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Use of Viscoelastic Assays Beyond Coagulation: Pre- and Post-operative TEG
Source: ClinicalTrials.gov · Last updated 24 Aug 2026
Brief summary (registry, in English)
The investigators hypothesize that abnormalities in thromboelastography (TEG) parameters in patients with liver, pancreas, biliary, esophageal, colorectal, and lung adenocarcinoma can serve as biomarkers for oncologic disease burden, cancer recurrence and overall survival as well as thrombotic and hemorrhagic post-operative complications. The investigators further hypothesize that there is histologic pathology correlates to pre-operative TEG abnormalities, and that it identifies patients with virulent tumor biology.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 4 Aug 2022
- Start date
- 26 Jun 2022
- Primary completion date
- 31 May 2028
- Lead sponsor
- University of Colorado, Denver
- Diseases
- Lung cancer, Pancreatic cancer, Colorectal cancer, Liver and biliary tract cancer, Gastric and esophageal cancer
- NCT number
- NCT05517811
What you commit to
- Study type: Observational
- Planned participants: 200
- From 26 Jun 2022 to the primary completion date, 31 May 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Under 18 years old
Other
- prisoners
- unable to provide informed consent
- pregnant women
- and those undergoing emergent or urgent operative intervention at the time of diagnosis
Who the study is looking for
- new diagnosis by the providing physician of hepatopancreaticobiliary, esophageal, colorectal, lung adenocarcinoma, or liver metastasis of any origin will be eligible for enrollment in the study
- 18 Years and older
Age in the registry: 18 years to 99 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Colorado Denver Coordinator of this site? Confirm its status | Aurora | United States | Recruiting |
| UCHealth Highlands Ranch Hospital Coordinator of this site? Confirm its status | Highlands Ranch | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.